Dr. Liang Cheng, Professor of Pathology and Professor of Surgery/Urology, and the Incoming President of the International Society of Urological Pathology (ISUP), has published an article in the October issue of European Urology, a journal with an impact factor of 23.

Prostate cancer is the most common cancer among men and the second leading cause of cancer-related death. The clinical behavior of prostate cancer is dictated by its biology and tumor grade. A better understanding of the clinical impact of pathological findings could aid in better stratifying surgically treated patients and identifying higher-risk individuals for adjuvant or salvage treatments. This Platinum Opinion calls on pathologists, urologists, and oncologists to collaborate closely for improved clinical management.

The full article is available at the following link: https://www.sciencedirect.com/science/article/pii/S0302283824021353